AV
ARCH Venture Management, LLC
CHICAGO IL · SEC CIK 0001274403
$1.10B2026Q2 reported value
12Positions
99.3%Top 10 weight · largest 16.0%
1 / 1New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
BOUNDLESS BIO IN New+$6.74M
2026Q2 top sells estimated at quarter-end value
VIR Reduced-$2.27M
QTTB Sold out-$2.06M
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| PBLS | PARABILIS MEDICINES INC | $175.52M | 15.95% | 6,412,780 | 6,412,780 | — | — | First reported |
| BEAM | BEAM THERAPEUTICS INC | $155.77M | 14.16% | 4,540,132 | 0 | 0.0% | — | Unchanged |
| RAPP | RAPPORT THERAPEUTICS INC | $155.38M | 14.12% | 3,728,738 | 0 | 0.0% | — | Unchanged |
| SPTX | SEAPORT THERAPEUTICS INC | $136.60M | 12.42% | 6,294,951 | 6,294,951 | — | — | First reported |
| ERAS | ERASCA INC | $129.92M | 11.81% | 7,091,557 | 0 | 0.0% | — | Unchanged |
| VIR | VIR BIOTECHNOLOGY INC | $129.35M | 11.76% | 12,694,163 | -222,500 | -1.7% | -$2.27M | Reduced |
| MAZE | MAZE THERAPEUTICS INC | $122.98M | 11.18% | 4,120,053 | 0 | 0.0% | — | Unchanged |
| LYEL | LYELL IMMUNOPHARMA INC | $45.53M | 4.14% | 3,247,162 | 0 | 0.0% | — | Unchanged |
| GENB | GENERATE BIOMEDICINES INC | $32.80M | 2.98% | 1,944,426 | 0 | 0.0% | — | Unchanged |
| TXG | 10X GENOMICS INC | $8.35M | 0.76% | 217,834 | 0 | 0.0% | — | Unchanged |
| — | BOUNDLESS BIO INC | $6.74M | 0.61% | 2,694,095 | 2,694,095 | — | $6.74M | New |
| — | GOSSAMER BIO INC | $1.33M | 0.12% | 8,055,916 | 0 | 0.0% | — | Unchanged |
| QTTB | Q32 BIO INC | $0 | 0.00% | 0 | -320,482 | -100.0% | -$2.06M | Sold out |